Synthesis and Computational Exploration of Morpholine Bearing Halogenated Sulfonamides as Potential Tyrosinase Inhibitors

被引:0
|
作者
Abbasi, Muhammad Athar [1 ]
Raza, Hussain [2 ]
Aziz-ur-Rehman, Sabahat Zahra
Siddiqui, Sabahat Zahra [1 ]
Muhammad, Shabbir [3 ,4 ]
Khan, Farhan Mehmood [1 ]
Shah, Syed Adnan Ali [5 ,6 ]
Al-Sehemi, Abdullah G. [3 ]
Kim, Song Ja [2 ]
机构
[1] Govt Coll Univ, Dept Chem, Lahore 54000, Pakistan
[2] Kongju Natl Univ, Coll Nat Sci, Dept Biol Sci, Gongju 32588, South Korea
[3] King Khalid Univ, Coll Sci, Dept Chem, POB 9004, Abha 61413, Saudi Arabia
[4] King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, POB 9004, Abha 61413, Saudi Arabia
[5] Univ Teknol MARA Cawangan Selangor Kampus Puncak A, Fac Pharm, Bandar Puncak Alam 42300, Selangor, Malaysia
[6] Univ Teknol MARA Cawangan Selangor Kampus Puncak A, Atta ur Rahman Inst Nat Prod Discovery AuRIns, Bandar Puncak Alam 42300, Selangor, Malaysia
基金
新加坡国家研究基金会;
关键词
3,5-dichloro-2-hydroxybenzenesulfonyl chloride; kinetic analysis; molecular docking; morpholine; tyrosinase; MOLECULAR DOCKING; PHARMACOLOGICAL EVALUATION; MUSHROOM TYROSINASE; DERIVATIVES; MECHANISM;
D O I
10.1002/cbdv.202300257
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the presented work, a new series of three different 4-((3,5-dichloro-2-[(2/4-halobenzyl)oxy]phenyl)sulfonyl)morpholines was synthesized and the structure of these compounds were corroborated by 1H-NMR & 13C-NMR studies. The in vitro results established all the three compounds as potent tyrosinase inhibitors relative to the standard. The Kinetics mechanism plots established that compound 8 inhibited the enzyme non-competitively. The inhibition constants Ki calculated from Dixon plots for this compound was 0.0025 & mu;M. Additionally, computational techniques were used to explore electronic structures of synthesized compounds. Fully optimized geometries were further docked with tyrosinase enzyme for inhibition studies. Reasonably good binding/interaction energies and intermolecular interactions were obtained. Finally, drug likeness was also predicted using the rule of five (RO5) and Chemical absorption, distribution, metabolism, excretion, and toxicity (ADMET) characteristics. It is anticipated that current experimental and computational investigations will evoke the scientific interest of the research community for the above-entitled compounds. image
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Unveiling the Anticancer Potential: Computational Exploration of Nitrogenated Derivatives of (+)-Pancratistatin as Topoisomerase I Inhibitors
    Mohamed, Magdi Awadalla
    Elsaman, Tilal
    Elderdery, Abozer Y.
    Alsrhani, Abdullah
    Ghanem, Heba Bassiony
    Alruwaili, Majed Mowanes
    Hamza, Siddiqa M. A.
    Mekki, Salma Elhadi Ibrahim
    Alotaibi, Hazim Abdullah
    Mills, Jeremy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [32] Novel imidazophenoxazine-4-sulfonamides: Their synthesis and evaluation as potential inhibitors of PDE4
    Reddy, Seelam Venkata
    Rao, Gangula Mohan
    Kumar, Baru Vijaya
    Meda, Chandana L. T.
    Deora, Girdhar Singh
    Kumar, K. Shiva
    Parsa, Kishore V. L.
    Pal, Manojit
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) : 1952 - 1963
  • [33] Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling
    Ghorab, Mostafa M.
    Ceruso, Mariangela
    Alsaid, Mansour S.
    Nissan, Yassin M.
    Arafa, Reem K.
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 : 186 - 196
  • [34] Nicotinonitriles as potential inhibitors of α-glucosidase, tyrosinase, and urease enzymes: Synthesis, characterization, in vitro, and in silico studies
    Khan, Maaz
    Ambreen, Nida
    Saleem, Faiza
    Lodhi, Muhammad Arif
    Jan, Faheem
    Kamal, Masroor
    Salar, Uzma
    Taha, Muhammad
    Khan, Khalid Mohammed
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1305
  • [35] Design, synthesis and computational studies of N-(substituted-phenyl)-4-(4-phenyl-1-piperazinyl)butanamides as potent anti-melanogenic and tyrosinase inhibitors
    Raza, Hussain
    Abbasi, Muhammad Athar
    Aziz-ur-Rehman
    Siddiqui, Sabahat Zahra
    Hassan, Mubashir
    Shah, Syed Adnan Ali
    Shahid, Muhammad
    Hong, Hansol
    Seo, Sung-Yum
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1210 (1210)
  • [36] Synthesis and molecular docking study of thiophene-bearing thiourea derivatives as potential acetylcholinesterase, and butyrylcholinesterase inhibitors
    Ullah, Hayat
    Bashir, Maria
    Khan, Fahad
    Iqbal, Iram
    Iqbal, Aroosa
    Rahim, Fazal
    CHEMICAL DATA COLLECTIONS, 2024, 50
  • [37] Design, Synthesis, and Anti-Melanogenic Activity of 2-Mercaptomethylbenzo[d]imidazole Derivatives Serving as Tyrosinase Inhibitors: An In Silico, In Vitro, and In Vivo Exploration
    Jung, Hee Jin
    Park, Hyeon Seo
    Kim, Hye Jin
    Park, Hye Soo
    Park, Yujin
    Chun, Pusoon
    Chung, Hae Young
    Moon, Hyung Ryong
    ANTIOXIDANTS, 2024, 13 (10)
  • [38] Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2
    Al-Suwaidan, Ibrahim A.
    Alanazi, Amer M.
    El-Azab, Adel S.
    Al-Obaid, Abdulrahman M.
    ElTahir, Kamal E. H.
    Maarouf, Azza R.
    Abu El-Enin, Mohamed A.
    Abdel-Aziz, Alaa A-M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2601 - 2605
  • [39] Design, synthesis and evaluation of pyrazole bearing α-aminophosphonate derivatives as potential acetylcholinesterase inhibitors against Alzheimer's disease
    Shaikh, Sarfaraz
    Dhavan, Pratik
    Pavale, Ganesh
    Ramana, M. M., V
    Jadhav, B. L.
    BIOORGANIC CHEMISTRY, 2020, 96
  • [40] Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
    Al-Sanea, Mohammad M.
    Hafez, Hani M.
    AB Mohamed, Ahmed
    El-Shafey, Hamed W.
    Elgazar, Abdullah A.
    Tawfik, Samar S.
    Ewes, Wafaa A.
    Hussein, Shaimaa
    Alsahli, Tariq G.
    Hamdi, Abdelrahman
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 5109 - 5127